| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.0065 | 1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |